Valuation: Envista Holdings Corporation

Capitalization 4.66B 4.01B 3.64B 3.49B 6.37B 429B 6.6B 42.71B 17.1B 205B 17.49B 17.11B 732B P/E ratio 2026 *
29.1x
P/E ratio 2027 * 25.4x
Enterprise value 4.39B 3.78B 3.43B 3.29B 6B 405B 6.22B 40.25B 16.11B 193B 16.48B 16.13B 689B EV / Sales 2026 *
1.54x
EV / Sales 2027 * 1.38x
Free-Float
98.02%
Yield 2026 *
-
Yield 2027 * -
1 day+0.30%
1 week-3.75%
Current month-3.46%
1 month+14.12%
3 months+39.40%
6 months+32.33%
Current year+29.89%
1 week 27.78
Extreme 27.775
29.66
1 month 26.74
Extreme 26.74
30.42
Current year 21.58
Extreme 21.575
30.42
1 year 14.22
Extreme 14.22
30.42
3 years 14.22
Extreme 14.22
40.92
5 years 14.22
Extreme 14.22
52.03
10 years 10.08
Extreme 10.08
52.03
Manager TitleAgeSince
Chief Executive Officer 56 01/05/2024
Director of Finance/CFO 51 08/08/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 01/01/2019
Director/Board Member 57 01/01/2019
Chairman 61 01/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
+0.28%-3.75%+54.61%-27.60% 4.66B
-1.22%-3.94%-18.90%+8.69% 197B
-1.45%-2.85%+0.22%+15.05% 123B
-2.89%-2.70%+41.83%+128.01% 71.62B
+2.64%-2.85%+55.94%+105.25% 58.8B
-1.32%-4.21%-24.49%-28.36% 48.83B
+1.71%-10.53% - - 34.8B
-0.56%-3.13%-12.09%-36.38% 28.06B
-0.95%-5.79%+5.51%+28.90% 23.84B
-0.88%-6.96%-10.30%-24.60% 18.73B
Average -0.48%-3.25%+10.26%+18.77% 60.86B
Weighted average by Cap. -0.90%-2.31%+2.19%+28.94%

Financials

2026 *2027 *
Net sales 2.84B 2.45B 2.22B 2.13B 3.89B 262B 4.03B 26.07B 10.44B 125B 10.67B 10.44B 446B 2.94B 2.53B 2.3B 2.2B 4.02B 271B 4.17B 26.99B 10.81B 129B 11.05B 10.82B 462B
Net income 160M 137M 125M 120M 218M 14.73B 226M 1.46B 586M 7.02B 600M 587M 25.09B 178M 153M 139M 133M 243M 16.39B 252M 1.63B 652M 7.82B 667M 653M 27.91B
Net Debt -269M -231M -210M -201M -367M -24.77B -381M -2.46B -986M -11.81B -1.01B -987M -42.2B -583M -501M -455M -436M -796M -53.72B -825M -5.34B -2.14B -25.62B -2.19B -2.14B -91.5B
Logo Envista Holdings Corporation
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Employees
12,000
Date Price Change Volume
05/03/26 28.20 $ -0.81% 29,165
04/03/26 28.43 $ -0.84% 1,320,903
03/03/26 28.67 $ -2.62% 2,755,518
02/03/26 29.44 $ +0.79% 2,502,890
27/02/26 29.21 $ -0.31% 2,479,518
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
28.43USD
Average target price
28.46USD
Spread / Average Target
+0.11%

Quarterly revenue - Rate of surprise